AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

Achieved in both Technology and Finance and Accounting segments, with demand improvement cited across offerings. Gross Margin ...

They may look the same, but they don't always work the same Greg DePersio has 13+ years of professional experience in sales and SEO and 3+ years as a writer and editor. Katie Miller is a consumer ...

AI agents are now being weaponized through prompt injection, exposing why model guardrails are not enough to protect enterprise data. If you can only read one tech story a day, this is it. We use ...